Jefferies Group Weighs in on Monsanto Co.’s Q1 2017 Earnings (MON)
Monsanto Co. (NYSE:MON) – Equities researchers at Jefferies Group issued their Q1 2017 EPS estimates for Monsanto in a research report issued on Thursday. Jefferies Group analyst L. Alexander forecasts that the firm will earn $0.04 per share for the quarter. Jefferies Group has a “Buy” rating on the stock. Jefferies Group also issued estimates for Monsanto’s Q2 2017 earnings at $2.47 EPS, Q3 2017 earnings at $2.04 EPS, Q4 2017 earnings at $0.09 EPS and FY2020 earnings at $7.35 EPS.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same quarter in the prior year, the company earned ($0.19) earnings per share. Monsanto’s revenue was up 8.8% on a year-over-year basis.
Other research analysts also recently issued reports about the company. Piper Jaffray Cos. restated an “overweight” rating and set a $127.00 price objective (up from $95.00) on shares of Monsanto in a report on Monday, June 13th. Barclays PLC restated a “hold” rating and set a $110.00 price objective on shares of Monsanto in a report on Thursday. Deutsche Bank AG restated a “buy” rating on shares of Monsanto in a report on Thursday. Zacks Investment Research downgraded Monsanto from a “hold” rating to a “strong sell” rating in a report on Friday. Finally, Argus restated a “buy” rating and set a $128.00 price objective (up from $111.00) on shares of Monsanto in a report on Wednesday, June 15th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Monsanto has an average rating of “Buy” and an average price target of $114.67.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/07/jefferies-group-weighs-in-on-monsanto-co-s-q1-2017-earnings-mon.html
Monsanto (NYSE:MON) traded up 0.091% on Friday, reaching $103.594. The company’s stock had a trading volume of 977,639 shares. The firm’s 50 day moving average price is $104.88 and its 200-day moving average price is $101.34. The company has a market capitalization of $45.33 billion, a price-to-earnings ratio of 45.596 and a beta of 1.19. Monsanto has a 1-year low of $83.73 and a 1-year high of $114.26.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is 71.05%.
In other news, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now owns 21,583 shares in the company, valued at approximately $2,196,501.91. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. WFG Advisors LP raised its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the period. Howard Hughes Medical Institute purchased a new stake in Monsanto during the first quarter valued at about $110,000. Signaturefd LLC increased its stake in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares in the last quarter. Mycio Wealth Partners LLC increased its stake in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares in the last quarter. Finally, Pinkerton Retirement Specialists LLC increased its stake in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares in the last quarter. Institutional investors own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.